Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Diet Pills Market by PRODUCT TYPE (Over the Counter, Prescription), by APPLICATION (Fat Blocking, Appetite Suppression, Others) by DISTRIBUTION CHANNEL (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) : Global Opportunity Analysis and Industry Forecast, 2022-2032

A50572

Pages: NA

Charts: NA

Tables: NA

Diet pill is medication or supplement that claim to aid weight loss by suppressing appetite, increasing metabolism, or blocking the absorption of fat. However, there is limited scientific evidence to support their effectiveness and safety. Some diet pills contain stimulants, such as caffeine, which can increase heart rate and blood pressure and cause jitteriness and anxiety. Other diet pills may contain ingredients that can have negative side effects, such as liver damage or gastrointestinal problems.

It is important to note that taking diet pills alone is not an effective long-term weight loss strategy. To achieve sustainable weight loss, it is important to focus on making healthy lifestyle changes, such as adopting a balanced diet and regular exercise routine. If you are considering taking diet pills, it is important to speak with a healthcare professional before starting, as they can provide guidance on the potential risks and benefits, and help you determine if it is a safe and appropriate choice for you.

As people become more health-conscious, the demand for weight loss products, including diet pills, is on the rise. There are a variety of factors driving this trend, including increasing rates of obesity, a focus on appearance, and advancements in product formulations. Obesity is a major health concern globally, and the prevalence of this condition has been steadily rising over the past several decades. This has led to a growing demand for weight loss products, as individuals seek solutions to help them achieve a healthier weight and reduce their risk of chronic diseases.

In addition to health concerns, there is also a growing focus on appearance and body image, with social media and other platforms promoting unrealistic beauty standards. This has led many individuals to seek out weight loss products, including diet pills, to help them achieve their ideal body shape. Advancements in product formulations have also contributed to the rising demand for diet pills. With new, more effective formulations backed by scientific research, these products are becoming more appealing to consumers looking for a safe and effective way to lose weight. Furthermore, the increased availability and accessibility of weight loss products, including diet pills, has contributed to their growing popularity. With e-commerce and other online sales channels, these products are becoming more widely available to consumers around the global.

In recent years, social media and other platforms that emphasize appearance have contributed to a growing focus on maintaining an ideal weight and body shape. This trend has had a significant impact on the demand for weight loss products, including diet pills. Social media platforms like Instagram, TikTok, and Facebook are filled with images and videos of idealized body types, often promoting unrealistic beauty standards. This has led to a rise in body dissatisfaction and a growing desire to achieve an ideal body shape, which is driving the demand for weight loss products. Furthermore, social media influencers and celebrities often endorse weight loss products, including diet pills, as part of their beauty and fitness routines. This endorsement can significantly impact the demand for these products, especially among younger audiences who are highly influenced by social media. The emphasis on appearance in media and society has also led to a rise in body shaming and negative self-talk, which can contribute to disordered eating and other mental health issues. This can further drive demand for weight loss products, as individuals seek to meet societal expectations and achieve a certain body type.

With the rise of e-commerce and other online sales channels, diet pills have become more widely available and accessible to consumers, which has contributed to the growing demand for these products. In the past, diet pills were primarily available through prescription, and obtaining them required a visit to a healthcare professional. However, the emergence of e-commerce has made it easier for consumers to purchase diet pills online, often without a prescription. This increased availability and accessibility have contributed to the growing popularity of diet pills, as consumers can easily obtain them without leaving their homes or visiting a healthcare professional. In addition, online retailers often offer a wider selection of diet pills, with different brands and formulations to choose from. Online reviews and ratings have also contributed to the increased demand for diet pills, as consumers can read about the experiences of others who have used the products. This can help consumers make more informed decisions about which diet pills to try and which to avoid.
 
New product launches to flourish in the market
In August 2021, the global pharmaceutical company, Pfizer, announced the launch of their new weight loss pill, Wegovy. The drug is a once-weekly injection that is designed to help people who are struggling with obesity to lose weight. The drug has been approved by the U.S. Food and Drug Administration (FDA) and is expected to be available in the market soon. In May 2021, the British pharmaceutical company, AstraZeneca, announced the launch of their new weight loss pill, called Bydureon BCise. The pill is a once-weekly injection that is designed to help people who are struggling with obesity to lose weight. The drug has been approved by the FDA and is expected to be available in the U.S. market soon.

Segment Overview: 
By product type: The diet pills market is divided into over the counter (OTC) and prescription. OTC and prescription. OTC diet pills are available for purchase without a prescription, and can be found in most drugstores, health stores, and online retailers. These products typically contain natural or synthetic ingredients that are believed to aid in weight loss, and are generally considered safe for most people to use. Prescription diet pills, on the other hand, are only available with a doctor's prescription. These products typically contain more potent ingredients than OTC diet pills, and are intended for use under the guidance of a healthcare professional.
 
By application: The diet pills market is divided into fat blocking, appetite suppression, and others. Fat-blocking diet pills work by preventing the absorption of dietary fats in the body, either by inhibiting the digestive enzymes that break down fat or by physically blocking the fat from being absorbed. Appetite suppression diet pills work by reducing the feeling of hunger, typically by increasing the production of certain hormones or neurotransmitters in the body. There are also other types of diet pills, such as those that increase metabolism or energy levels, or those that target specific areas of the body, such as the belly or thighs. 
 
By distribution channel: The diet pills market is divided into drug stores & retail pharmacies, hospital pharmacies, and online pharmacies. Drug stores and retail pharmacies are the most common distribution channels for diet pills, with products being sold over-the-counter at these outlets. Hospital pharmacies are another distribution channel, typically for prescription diet pills that are used under the guidance of a healthcare professional. Online pharmacies have also become a popular distribution channel for diet pills, allowing consumers to purchase products from the comfort of their own homes. However, it's important to note that consumers should exercise caution when purchasing diet pills online and ensure that the products are from reputable sources.
 
By region: The Asia-Pacific (APAC) diet pills market is one of the fastest-growing markets globally. The market is being driven by several factors, including the regions large and growing population, rising disposable income, increasing health awareness, and changing dietary habits. In addition, the growing prevalence of obesity and related health conditions, such as diabetes and cardiovascular disease, is also contributing to the increasing demand for weight loss products in the region. Countries such as China, Japan, India, and Australia are expected to be the major contributors to the growth of the APAC diet pills market. Overall, the APAC diet pills market is expected to continue to see strong growth in the coming years, driven by these and other factors.
 
Competitive analysis and profiles of the major players in the diet pills market, such as Arena Pharmaceuticals, Inc., Chong's Health Care, Currax Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd., Gelesis S.R.L., GlaxoSmithKline plc, Herbalife Ltd., Novo Nordisk A/S, Nutrisystem Ltd., and Zoller Laboratories are included in the report. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the diet pills market.    

Key Market Segments

  • By PRODUCT TYPE
    • Over the Counter
    • Prescription
  • By APPLICATION
    • Fat Blocking
    • Appetite Suppression
    • Others
  • By DISTRIBUTION CHANNEL
    • Drug Stores & Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
      • Malaysia
      • Indonesia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Argentina
      • Rest of LAMEA


Key Market Players

  • Novo Nordisk A/S
  • F. Hoffmann-La Roche Ltd.
  • Arena Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Chong's Health Care
  • Nutrisystem Limited
  • Currax Pharmaceuticals LLC
  • Herbalife Limited
  • Zoller Laboratories
  • Gelesis S.R.L.

TABLE OF CONTENTS

  • CHAPTER 1:    INTRODUCTION

    • 1.1.   Report description

    • 1.2.   Key benefits for stakeholders

    • 1.3.   Key market segments

    • 1.4.   Research methodology

      • 1.4.1.   Primary research

      • 1.4.2.   Secondary research

      • 1.4.3.   Analyst tools and models

    CHAPTER 2:    EXECUTIVE SUMMARY

    • 2.1.   Key findings of the study

    • 2.2.   CXO perspective

    CHAPTER 3:    MARKET OVERVIEW

    • 3.1.   Market definition and scope

    • 3.2.   Key findings

      • 3.2.1.   Top investment pockets

      • 3.2.2.   Top wining strategies

    • 3.3.   Porter’s five forces analysis

    • 3.4.   Top player positioning/Market share analysis

    • 3.5.   Market dynamics

      • 3.5.1.   Drivers

      • 3.5.2.   Restraint

      • 3.5.3.   Opportunity

    • 3.6.   COVID-19 Impact Analysis

  • CHAPTER 4 : DIET PILLS , BY PRODUCT TYPE

    • 4.1.   Overview

      • 4.1.1 Market size and forecast, by product type

    • 4.2.   Over the Counter

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis, by country

    • 4.3.   Prescription

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis, by country

  • CHAPTER 5 : DIET PILLS , BY APPLICATION

    • 5.1.   Overview

      • 5.1.1 Market size and forecast, by application

    • 5.2.   Fat Blocking

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis, by country

    • 5.3.   Appetite Suppression

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis, by country

    • 5.4.   Others

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis, by country

  • CHAPTER 6 : DIET PILLS , BY DISTRIBUTION CHANNEL

    • 6.1.   Overview

      • 6.1.1 Market size and forecast, by distribution channel

    • 6.2.   Drug Stores & Retail Pharmacies

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis, by country

    • 6.3.   Hospital Pharmacies

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis, by country

    • 6.4.   Online Pharmacies

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis, by country

  • CHAPTER 7 : DIET PILLS , BY REGIONS

    • 7.1.  Overview

    • 7.2.  NORTH AMERICA

      • 7.2.1. Key market trends, growth factors, and opportunities

      • 7.2.2. Market size and forecast, by product type

      • 7.2.3. Market size and forecast, by application

      • 7.2.4. Market size and forecast, by distribution channel

      • 7.2.5. Market size and forecast, by country

      • 7.2.6. U.S.

        • 7.2.6.1. Key market trends, growth factors, and opportunities

        • 7.2.6.2 Market size and forecast, by product type

        • 7.2.6.3 Market size and forecast, by application

        • 7.2.6.4 Market size and forecast, by distribution channel

      • 7.2.7. Canada

        • 7.2.7.1. Key market trends, growth factors, and opportunities

        • 7.2.7.2 Market size and forecast, by product type

        • 7.2.7.3 Market size and forecast, by application

        • 7.2.7.4 Market size and forecast, by distribution channel

      • 7.2.8. Mexico

        • 7.2.8.1. Key market trends, growth factors, and opportunities

        • 7.2.8.2 Market size and forecast, by product type

        • 7.2.8.3 Market size and forecast, by application

        • 7.2.8.4 Market size and forecast, by distribution channel

    • 7.3.  EUROPE

      • 7.3.1. Key market trends, growth factors, and opportunities

      • 7.3.2. Market size and forecast, by product type

      • 7.3.3. Market size and forecast, by application

      • 7.3.4. Market size and forecast, by distribution channel

      • 7.3.5. Market size and forecast, by country

      • 7.3.6. France

        • 7.3.6.1. Key market trends, growth factors, and opportunities

        • 7.3.6.2 Market size and forecast, by product type

        • 7.3.6.3 Market size and forecast, by application

        • 7.3.6.4 Market size and forecast, by distribution channel

      • 7.3.7. Germany

        • 7.3.7.1. Key market trends, growth factors, and opportunities

        • 7.3.7.2 Market size and forecast, by product type

        • 7.3.7.3 Market size and forecast, by application

        • 7.3.7.4 Market size and forecast, by distribution channel

      • 7.3.8. Italy

        • 7.3.8.1. Key market trends, growth factors, and opportunities

        • 7.3.8.2 Market size and forecast, by product type

        • 7.3.8.3 Market size and forecast, by application

        • 7.3.8.4 Market size and forecast, by distribution channel

      • 7.3.9. Spain

        • 7.3.9.1. Key market trends, growth factors, and opportunities

        • 7.3.9.2 Market size and forecast, by product type

        • 7.3.9.3 Market size and forecast, by application

        • 7.3.9.4 Market size and forecast, by distribution channel

      • 7.3.10. UK

        • 7.3.10.1. Key market trends, growth factors, and opportunities

        • 7.3.10.2 Market size and forecast, by product type

        • 7.3.10.3 Market size and forecast, by application

        • 7.3.10.4 Market size and forecast, by distribution channel

      • 7.3.11. Russia

        • 7.3.11.1. Key market trends, growth factors, and opportunities

        • 7.3.11.2 Market size and forecast, by product type

        • 7.3.11.3 Market size and forecast, by application

        • 7.3.11.4 Market size and forecast, by distribution channel

      • 7.3.12. Rest of Europe

        • 7.3.12.1. Key market trends, growth factors, and opportunities

        • 7.3.12.2 Market size and forecast, by product type

        • 7.3.12.3 Market size and forecast, by application

        • 7.3.12.4 Market size and forecast, by distribution channel

    • 7.4.  ASIA-PACIFIC

      • 7.4.1. Key market trends, growth factors, and opportunities

      • 7.4.2. Market size and forecast, by product type

      • 7.4.3. Market size and forecast, by application

      • 7.4.4. Market size and forecast, by distribution channel

      • 7.4.5. Market size and forecast, by country

      • 7.4.6. China

        • 7.4.6.1. Key market trends, growth factors, and opportunities

        • 7.4.6.2 Market size and forecast, by product type

        • 7.4.6.3 Market size and forecast, by application

        • 7.4.6.4 Market size and forecast, by distribution channel

      • 7.4.7. Japan

        • 7.4.7.1. Key market trends, growth factors, and opportunities

        • 7.4.7.2 Market size and forecast, by product type

        • 7.4.7.3 Market size and forecast, by application

        • 7.4.7.4 Market size and forecast, by distribution channel

      • 7.4.8. India

        • 7.4.8.1. Key market trends, growth factors, and opportunities

        • 7.4.8.2 Market size and forecast, by product type

        • 7.4.8.3 Market size and forecast, by application

        • 7.4.8.4 Market size and forecast, by distribution channel

      • 7.4.9. South Korea

        • 7.4.9.1. Key market trends, growth factors, and opportunities

        • 7.4.9.2 Market size and forecast, by product type

        • 7.4.9.3 Market size and forecast, by application

        • 7.4.9.4 Market size and forecast, by distribution channel

      • 7.4.10. Australia

        • 7.4.10.1. Key market trends, growth factors, and opportunities

        • 7.4.10.2 Market size and forecast, by product type

        • 7.4.10.3 Market size and forecast, by application

        • 7.4.10.4 Market size and forecast, by distribution channel

      • 7.4.11. Thailand

        • 7.4.11.1. Key market trends, growth factors, and opportunities

        • 7.4.11.2 Market size and forecast, by product type

        • 7.4.11.3 Market size and forecast, by application

        • 7.4.11.4 Market size and forecast, by distribution channel

      • 7.4.12. Malaysia

        • 7.4.12.1. Key market trends, growth factors, and opportunities

        • 7.4.12.2 Market size and forecast, by product type

        • 7.4.12.3 Market size and forecast, by application

        • 7.4.12.4 Market size and forecast, by distribution channel

      • 7.4.13. Indonesia

        • 7.4.13.1. Key market trends, growth factors, and opportunities

        • 7.4.13.2 Market size and forecast, by product type

        • 7.4.13.3 Market size and forecast, by application

        • 7.4.13.4 Market size and forecast, by distribution channel

      • 7.4.14. Rest of Asia-Pacific

        • 7.4.14.1. Key market trends, growth factors, and opportunities

        • 7.4.14.2 Market size and forecast, by product type

        • 7.4.14.3 Market size and forecast, by application

        • 7.4.14.4 Market size and forecast, by distribution channel

    • 7.5.  LAMEA

      • 7.5.1. Key market trends, growth factors, and opportunities

      • 7.5.2. Market size and forecast, by product type

      • 7.5.3. Market size and forecast, by application

      • 7.5.4. Market size and forecast, by distribution channel

      • 7.5.5. Market size and forecast, by country

      • 7.5.6. Brazil

        • 7.5.6.1. Key market trends, growth factors, and opportunities

        • 7.5.6.2 Market size and forecast, by product type

        • 7.5.6.3 Market size and forecast, by application

        • 7.5.6.4 Market size and forecast, by distribution channel

      • 7.5.7. South Africa

        • 7.5.7.1. Key market trends, growth factors, and opportunities

        • 7.5.7.2 Market size and forecast, by product type

        • 7.5.7.3 Market size and forecast, by application

        • 7.5.7.4 Market size and forecast, by distribution channel

      • 7.5.8. Saudi Arabia

        • 7.5.8.1. Key market trends, growth factors, and opportunities

        • 7.5.8.2 Market size and forecast, by product type

        • 7.5.8.3 Market size and forecast, by application

        • 7.5.8.4 Market size and forecast, by distribution channel

      • 7.5.9. UAE

        • 7.5.9.1. Key market trends, growth factors, and opportunities

        • 7.5.9.2 Market size and forecast, by product type

        • 7.5.9.3 Market size and forecast, by application

        • 7.5.9.4 Market size and forecast, by distribution channel

      • 7.5.10. Argentina

        • 7.5.10.1. Key market trends, growth factors, and opportunities

        • 7.5.10.2 Market size and forecast, by product type

        • 7.5.10.3 Market size and forecast, by application

        • 7.5.10.4 Market size and forecast, by distribution channel

      • 7.5.11. Rest of LAMEA

        • 7.5.11.1. Key market trends, growth factors, and opportunities

        • 7.5.11.2 Market size and forecast, by product type

        • 7.5.11.3 Market size and forecast, by application

        • 7.5.11.4 Market size and forecast, by distribution channel

  • CHAPTER 8: COMPANY LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2022

  • CHAPTER 9 : COMPANY PROFILES

    • 9.1. NOVO NORDISK A/S

      • 9.1.1. Company overview

      • 9.1.2. Business performance

      • 9.1.3. Key strategic moves and developments

    • 9.2. GELESIS S.R.L.

      • 9.2.1. Company overview

      • 9.2.2. Business performance

      • 9.2.3. Key strategic moves and developments

    • 9.3. GLAXOSMITHKLINE PLC

      • 9.3.1. Company overview

      • 9.3.2. Business performance

      • 9.3.3. Key strategic moves and developments

    • 9.4. ZOLLER LABORATORIES

      • 9.4.1. Company overview

      • 9.4.2. Business performance

      • 9.4.3. Key strategic moves and developments

    • 9.5. CHONG'S HEALTH CARE

      • 9.5.1. Company overview

      • 9.5.2. Business performance

      • 9.5.3. Key strategic moves and developments

    • 9.6. HERBALIFE LIMITED

      • 9.6.1. Company overview

      • 9.6.2. Business performance

      • 9.6.3. Key strategic moves and developments

    • 9.7. CURRAX PHARMACEUTICALS LLC

      • 9.7.1. Company overview

      • 9.7.2. Business performance

      • 9.7.3. Key strategic moves and developments

    • 9.8. F. HOFFMANN-LA ROCHE LTD.

      • 9.8.1. Company overview

      • 9.8.2. Business performance

      • 9.8.3. Key strategic moves and developments

    • 9.9. NUTRISYSTEM LIMITED

      • 9.9.1. Company overview

      • 9.9.2. Business performance

      • 9.9.3. Key strategic moves and developments

    • 9.10. ARENA PHARMACEUTICALS, INC.

      • 9.10.1. Company overview

      • 9.10.2. Business performance

      • 9.10.3. Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DIET PILLS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL DIET PILLS MARKET FOR OVER THE COUNTER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL DIET PILLS MARKET FOR OVER THE COUNTER, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL DIET PILLS MARKET FOR PRESCRIPTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL DIET PILLS MARKET FOR PRESCRIPTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL DIET PILLS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL DIET PILLS MARKET FOR FAT BLOCKING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL DIET PILLS MARKET FOR FAT BLOCKING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL DIET PILLS MARKET FOR APPETITE SUPPRESSION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL DIET PILLS MARKET FOR APPETITE SUPPRESSION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL DIET PILLS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL DIET PILLS MARKET FOR OTHERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL DIET PILLS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL DIET PILLS MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL DIET PILLS MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL DIET PILLS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL DIET PILLS MARKET FOR HOSPITAL PHARMACIES, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL DIET PILLS MARKET FOR ONLINE PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL DIET PILLS MARKET FOR ONLINE PHARMACIES, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL DIET PILLS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA DIET PILLS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE DIET PILLS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC DIET PILLS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 39. REST OF ASIA-PACIFIC DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 40. REST OF ASIA-PACIFIC DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. REST OF ASIA-PACIFIC DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 42. LAMEA DIET PILLS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 43. LAMEA DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. LAMEA DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. LAMEA DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 46. REST OF LAMEA DIET PILLS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF LAMEA DIET PILLS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. REST OF LAMEA DIET PILLS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 49. NOVO NORDISK A/S: KEY EXECUTIVES
  • TABLE 50. NOVO NORDISK A/S: COMPANY SNAPSHOT
  • TABLE 51. NOVO NORDISK A/S: OPERATING SEGMENTS
  • TABLE 52. NOVO NORDISK A/S: PRODUCT PORTFOLIO
  • TABLE 53. NOVO NORDISK A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 54. GELESIS S.R.L.: KEY EXECUTIVES
  • TABLE 55. GELESIS S.R.L.: COMPANY SNAPSHOT
  • TABLE 56. GELESIS S.R.L.: OPERATING SEGMENTS
  • TABLE 57. GELESIS S.R.L.: PRODUCT PORTFOLIO
  • TABLE 58. GELESIS S.R.L.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 59. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
  • TABLE 60. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • TABLE 61. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
  • TABLE 62. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
  • TABLE 63. GLAXOSMITHKLINE PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 64. ZOLLER LABORATORIES: KEY EXECUTIVES
  • TABLE 65. ZOLLER LABORATORIES: COMPANY SNAPSHOT
  • TABLE 66. ZOLLER LABORATORIES: OPERATING SEGMENTS
  • TABLE 67. ZOLLER LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 68. ZOLLER LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 69. CHONG'S HEALTH CARE: KEY EXECUTIVES
  • TABLE 70. CHONG'S HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 71. CHONG'S HEALTH CARE: OPERATING SEGMENTS
  • TABLE 72. CHONG'S HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 73. CHONG'S HEALTH CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 74. HERBALIFE LIMITED: KEY EXECUTIVES
  • TABLE 75. HERBALIFE LIMITED: COMPANY SNAPSHOT
  • TABLE 76. HERBALIFE LIMITED: OPERATING SEGMENTS
  • TABLE 77. HERBALIFE LIMITED: PRODUCT PORTFOLIO
  • TABLE 78. HERBALIFE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. CURRAX PHARMACEUTICALS LLC: KEY EXECUTIVES
  • TABLE 80. CURRAX PHARMACEUTICALS LLC: COMPANY SNAPSHOT
  • TABLE 81. CURRAX PHARMACEUTICALS LLC: OPERATING SEGMENTS
  • TABLE 82. CURRAX PHARMACEUTICALS LLC: PRODUCT PORTFOLIO
  • TABLE 83. CURRAX PHARMACEUTICALS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 85. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 86. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 87. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 88. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. NUTRISYSTEM LIMITED: KEY EXECUTIVES
  • TABLE 90. NUTRISYSTEM LIMITED: COMPANY SNAPSHOT
  • TABLE 91. NUTRISYSTEM LIMITED: OPERATING SEGMENTS
  • TABLE 92. NUTRISYSTEM LIMITED: PRODUCT PORTFOLIO
  • TABLE 93. NUTRISYSTEM LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. ARENA PHARMACEUTICALS, INC.: KEY EXECUTIVES
  • TABLE 95. ARENA PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
  • TABLE 96. ARENA PHARMACEUTICALS, INC.: OPERATING SEGMENTS
  • TABLE 97. ARENA PHARMACEUTICALS, INC.: PRODUCT PORTFOLIO
  • TABLE 98. ARENA PHARMACEUTICALS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DIET PILLS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DIET PILLS MARKET
  • FIGURE 3. SEGMENTATION DIET PILLS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DIET PILLS MARKET
  • FIGURE 5. TOP WINNING STRATEGIES, 2020-2022*
  • FIGURE 6. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*(%)
  • FIGURE 7. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 8. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 9. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 10. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 10. LOW THREAT OF SUBSTITUTION
  • FIGURE 11. HIGH COMPETITIVE RIVALRY
  • FIGURE 12. TOP PLAYER POSITIONING, 2022
  • FIGURE 13. MARKET SHARE ANALYSIS, 2022
  • FIGURE 14. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIET PILLS MARKET
  • FIGURE 15. DIET PILLS MARKET SEGMENTATION, BY PRODUCT TYPE
  • FIGURE 16. DIET PILLS MARKET FOR OVER THE COUNTER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. DIET PILLS MARKET FOR PRESCRIPTION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. DIET PILLS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 19. DIET PILLS MARKET FOR FAT BLOCKING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. DIET PILLS MARKET FOR APPETITE SUPPRESSION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. DIET PILLS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. DIET PILLS MARKET SEGMENTATION, BY DISTRIBUTION CHANNEL
  • FIGURE 23. DIET PILLS MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. DIET PILLS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. DIET PILLS MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. NOVO NORDISK A/S: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 27. NOVO NORDISK A/S: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 28. NOVO NORDISK A/S: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 29. GELESIS S.R.L.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. GELESIS S.R.L.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. GELESIS S.R.L.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. GLAXOSMITHKLINE PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. ZOLLER LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. ZOLLER LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. ZOLLER LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. CHONG'S HEALTH CARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. CHONG'S HEALTH CARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. CHONG'S HEALTH CARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. HERBALIFE LIMITED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. HERBALIFE LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. HERBALIFE LIMITED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. CURRAX PHARMACEUTICALS LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. CURRAX PHARMACEUTICALS LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. CURRAX PHARMACEUTICALS LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. NUTRISYSTEM LIMITED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. NUTRISYSTEM LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. NUTRISYSTEM LIMITED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. ARENA PHARMACEUTICALS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. ARENA PHARMACEUTICALS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. ARENA PHARMACEUTICALS, INC.: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
Diet Pills Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue